![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1875-6190|7|3|228-237
ISSN: 1570-159X
Source: Current Neuropharmacology, Vol.7, Iss.3, 2009-09, pp. : 228-237
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Neuroprotective agents in traumatic brain injury
By Maas A.I.
Expert Opinion on Investigational Drugs, Vol. 10, Iss. 4, 2001-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Biomarkers in Silent Traumatic Brain Injury
Current Pharmaceutical Design, Vol. 22, Iss. 6, 2016-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Oxidative Stress in Traumatic Brain Injury
Current Medicinal Chemistry, Vol. 21, Iss. 10, 2014-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Fine-tuning neuromodulation by adenosine
By Sebastiao A.M. Ribeiro J.A.
Trends in Pharmacological Sciences, Vol. 21, Iss. 9, 2000-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bridge Between Neuroimmunity and Traumatic Brain Injury
Current Pharmaceutical Design, Vol. 20, Iss. 26, 2014-08 ,pp. :